{"id":"https://openalex.org/W2052586705","doi":"https://doi.org/10.1046/j.1471-4159.2000.0740199.x","title":"Role of Corticotropin\u2010Releasing Factor Receptor\u20101 in Opiate Withdrawal","display_name":"Role of Corticotropin\u2010Releasing Factor Receptor\u20101 in Opiate Withdrawal","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W2052586705","doi":"https://doi.org/10.1046/j.1471-4159.2000.0740199.x","mag":"2052586705","pmid":"https://pubmed.ncbi.nlm.nih.gov/10617121"},"language":"en","primary_location":{"id":"doi:10.1046/j.1471-4159.2000.0740199.x","doi":"https://doi.org/10.1046/j.1471-4159.2000.0740199.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.2000.0740199.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048555311","display_name":"Philip A. Iredale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip A. Iredale","raw_affiliation_strings":["Central Research Division, Pfizer, Inc., Groton, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Division, Pfizer, Inc., Groton, Connecticut, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036868755","display_name":"John D. Alvaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John D. Alvaro","raw_affiliation_strings":["Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","Yale University, New Haven, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]},{"raw_affiliation_string":"Yale University, New Haven, United States","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Younglim Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Younglim Lee","raw_affiliation_strings":["Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","Yale University, New Haven, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]},{"raw_affiliation_string":"Yale University, New Haven, United States","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110124701","display_name":"Rosemarie Z. Terwilliger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rosemarie Terwilliger","raw_affiliation_strings":["Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","Yale University, New Haven, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]},{"raw_affiliation_string":"Yale University, New Haven, United States","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009999364","display_name":"Yuhpyng L. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuhpyng L. Chen","raw_affiliation_strings":["Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","Yale University, New Haven, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]},{"raw_affiliation_string":"Yale University, New Haven, United States","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087594298","display_name":"Ronald S. Duman","orcid":"https://orcid.org/0000-0001-8690-8439","observed_orcids":["https://orcid.org/0000-0001-8690-8439"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald S. Duman","raw_affiliation_strings":["Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","Yale University, New Haven, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Psychiatry, Departments of Psychiatry and  Pharmacology, Yale University School of Medicine, Connecticut Mental Health  Center, New Haven, Connecticut, U.S.A.*Central Research Division, Pfizer, Inc., Groton, Connecticut,  U.S.A","institution_ids":["https://openalex.org/I32971472","https://openalex.org/I4210155461"]},{"raw_affiliation_string":"Yale University, New Haven, United States","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":2.7935,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.91389922,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"74","issue":"1","first_page":"199","last_page":"208"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/corticotropin-releasing-factor","display_name":"corticotropin-releasing factor","score":0.9459999799728394},{"id":"https://openalex.org/keywords/crf1-receptor","display_name":"CRF1 receptor","score":0.9169999957084656},{"id":"https://openalex.org/keywords/crf-receptor-2","display_name":"CRF receptor 2","score":0.9129999876022339},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.9660000205039978},{"id":"https://openalex.org/keywords/morphine-withdrawal","display_name":"morphine withdrawal","score":0.9819999933242798},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9419999718666077},{"id":"https://openalex.org/keywords/cp-154-526","display_name":"CP-154,526","score":0.9750000238418579},{"id":"https://openalex.org/keywords/anxiety-like-behavior","display_name":"anxiety-like behavior","score":0.7080000042915344},{"id":"https://openalex.org/keywords/aversive-behavior","display_name":"aversive behavior","score":0.8339999914169312},{"id":"https://openalex.org/keywords/brain-regions","display_name":"brain regions","score":0.30300000309944153}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.666703462600708},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6647422313690186},{"id":"https://openalex.org/C100691959","wikidata":"https://www.wikidata.org/wiki/Q6410625","display_name":"Kindling","level":3,"score":0.6442508697509766},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.5804086923599243},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.5792405009269714},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.5453842878341675},{"id":"https://openalex.org/C2778062832","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Drug withdrawal","level":3,"score":0.4774775505065918},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4608584940433502},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.44918522238731384},{"id":"https://openalex.org/C2778458438","wikidata":"https://www.wikidata.org/wiki/Q386664","display_name":"Corticotropin-releasing hormone","level":3,"score":0.443353533744812},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.43813925981521606},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.43077394366264343},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.4234296381473541},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4231751561164856},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3143742084503174},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21727457642555237},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.1851191520690918},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.08971631526947021}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018019","descriptor_name":"Receptors, Corticotropin-Releasing Hormone","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018019","descriptor_name":"Receptors, Corticotropin-Releasing Hormone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018019","descriptor_name":"Receptors, Corticotropin-Releasing Hormone","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020033","descriptor_name":"Protein Isoforms","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1471-4159.2000.0740199.x","doi":"https://doi.org/10.1046/j.1471-4159.2000.0740199.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.2000.0740199.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:10617121","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10617121","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G390464691","display_name":null,"funder_award_id":"MH-45481","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G6806056144","display_name":null,"funder_award_id":"MH 53199","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G8966433368","display_name":"Molecular Neurobiology of Drug Addiction","funder_award_id":"P01DA008227","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1671645500","https://openalex.org/W1842207656","https://openalex.org/W1909195053","https://openalex.org/W1950744654","https://openalex.org/W1951492130","https://openalex.org/W1966425023","https://openalex.org/W1969779239","https://openalex.org/W1974253960","https://openalex.org/W1987852700","https://openalex.org/W1990678641","https://openalex.org/W1995227746","https://openalex.org/W2001418538","https://openalex.org/W2003570919","https://openalex.org/W2005731408","https://openalex.org/W2006503862","https://openalex.org/W2010827811","https://openalex.org/W2011692127","https://openalex.org/W2017168736","https://openalex.org/W2017919348","https://openalex.org/W2023079553","https://openalex.org/W2031065194","https://openalex.org/W2037593319","https://openalex.org/W2039548187","https://openalex.org/W2044331640","https://openalex.org/W2046934118","https://openalex.org/W2052816582","https://openalex.org/W2054220692","https://openalex.org/W2059057041","https://openalex.org/W2068818952","https://openalex.org/W2079718339","https://openalex.org/W2084334681","https://openalex.org/W2087334617","https://openalex.org/W2087389654","https://openalex.org/W2091456614","https://openalex.org/W2096820695","https://openalex.org/W2113983630","https://openalex.org/W2124997151","https://openalex.org/W2127552596","https://openalex.org/W2142819637","https://openalex.org/W2159650364","https://openalex.org/W2171846995","https://openalex.org/W2214956132","https://openalex.org/W2287658356","https://openalex.org/W2334462456","https://openalex.org/W2340023437","https://openalex.org/W2405951106","https://openalex.org/W2412009089","https://openalex.org/W2419249579","https://openalex.org/W4250686555"],"related_works":["https://openalex.org/W2033108647","https://openalex.org/W2003719731","https://openalex.org/W2113284090","https://openalex.org/W2023402726","https://openalex.org/W2790581461","https://openalex.org/W1965230396","https://openalex.org/W2072168887","https://openalex.org/W7008632197","https://openalex.org/W2002528951","https://openalex.org/W2089889688"],"abstract_inverted_index":{"Previous":[0],"studies":[1],"indicate":[2,172],"that":[3,173,193],"corticotropin-releasing":[4],"factor":[5],"(CRF)":[6],"contributes":[7,195],"to":[8,196],"the":[9,26,35,53,76,82,93,115,128,136,151,166,176,180,183,197],"anxiety-like":[10],"and":[11,72,123,168],"aversive":[12],"states":[13],"associated":[14],"with":[15,52],"drug-induced":[16],"withdrawal.":[17,80,100],"The":[18],"present":[19],"study":[20],"extends":[21],"this":[22,96,161],"work":[23],"by":[24,146],"analyzing":[25],"CRF":[27,40,139,184],"receptor":[28,97,140,162,169],"subtype":[29],"involved":[30],"in":[31,98,105,110,127,148],"withdrawal":[32,47,103,147],"responses.":[33],"First,":[34],"influence":[36],"of":[37,61,79,84,92,95,107,134,150,160,179,182],"a":[38,89],"selective":[39],"receptor-1":[41],"(CRF-R1)":[42],"antagonist,":[43],"CP-154,526,":[44],"on":[45,186],"opiate":[46,99,187],"behavior":[48],"was":[49,86,142],"examined.":[50],"Pretreatment":[51],"CRF-R1":[54,85,108,174],"antagonist":[55],"significantly":[56,145,157],"attenuated":[57],"several":[58,111],"behavioral":[59,167],"signs":[60],"naltrexone-induced":[62],"morphine":[63,102,155],"withdrawal,":[64,188],"including":[65,114],"writhing,":[66],"chewing,":[67],"weight":[68],"loss,":[69],"lacrimation,":[70],"salivation,":[71],"irritability,":[73],"measured":[74],"during":[75],"first":[77],"hour":[78],"Next":[81],"expression":[83],"determined":[87],"as":[88],"second":[90],"measure":[91],"involvement":[94],"Naltrexone-induced":[101],"resulted":[104],"down-regulation":[106],"mRNA":[109],"brain":[112],"regions,":[113],"frontal":[116],"cortex,":[117,119],"parietal":[118],"striatum,":[120],"nucleus":[121],"accumbens,":[122],"amygdala,":[124],"but":[125],"not":[126,143],"hypothalamus":[129],"or":[130],"periaqueductal":[131],"gray.":[132],"Expression":[133],"CRF-R2,":[135],"other":[137],"major":[138],"subtype,":[141],"down-regulated":[144],"any":[149],"regions":[152],"examined,":[153],"although":[154,189],"alone":[156],"increased":[158],"levels":[159],"subtype.":[163],"Taken":[164],"together,":[165],"regulation":[170],"findings":[171],"is":[175,191],"primary":[177],"mediator":[178],"actions":[181],"system":[185],"it":[190],"possible":[192],"CRF-R2":[194],"response.":[198]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}